EFFECT OF CHRONIC-RENAL-FAILURE ON HIGH-DENSITY-LIPOPROTEIN KINETICS

被引:46
|
作者
FUH, MMT
LEE, CM
JENG, CY
SHEN, DC
SHIEH, SM
REAVEN, GM
CHEN, YDI
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,STANFORD,CA 94305
[2] NATL DEF MED CTR,TRI SERV GEN HOSP,DEPT MED,TAIPEI,TAIWAN
[3] NATL DEF MED CTR,TRI SERV GEN HOSP,CLIN RES LAB,TAIPEI,TAIWAN
关键词
D O I
10.1038/ki.1990.114
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Plasma lipid and lipoprotein concentration and high density lipoprotein (HDL) kinetics were determined in control subjects and patients with chronic renal failure (CRF). Results demonstrated that plasma triglyceride (TG) concentration was significantly higher (P < 0.001) in patients with CRF, associated with a significant increase in plasma VLDL-cholesterol (P < 0.002) and a significant decrease (P < 0.05) in plasma HDL-cholesterol concentration. The rate of removal of 125I-apoAI/ HDL from plasma was slower (P < 0.001) in the patients with CRF, resulting in an increase in the residence time of 125I-apoAI/HDL (P < 0.001) and a decrease in the fractional catabolic rate (P < 0.001). Since plasma apoAI concentration was lower in patients with CRF, total apoAI/HDL synthetic rate was also significantly (P < 0.05) decreased. These data provide support for the view that low plasma HDL-cholesterol concentrations in patients with CRF are related to decreases in the synthetic rate of apoAI/HDL.
引用
收藏
页码:1295 / 1300
页数:6
相关论文
共 50 条
  • [41] GENETIC HIGH-DENSITY-LIPOPROTEIN DEFICIENCY
    SCHAEFER, EJ
    MCNAMARA, JR
    GENEST, J
    ORDOVAS, JM
    HIGH DENSITY LIPOPROTEINS AND ATHEROSCLEROSIS II, 1989, 826 : 79 - 86
  • [42] HIGH-DENSITY-LIPOPROTEIN SUBCLASSES IN DIABETES
    BERGMAN, M
    GIDEZ, LI
    EDER, HA
    AMERICAN JOURNAL OF MEDICINE, 1986, 81 (03): : 488 - 492
  • [43] THE EFFECT OF FENOLDOPAM ON RENAL HEMODYNAMICS AND NATRIURESIS IN CHRONIC-RENAL-FAILURE
    DEFIJTER, CWH
    COMANS, EFI
    DEVRIES, PMJM
    OE, PL
    ROOS, JC
    SMIT, AJ
    STREURMAN, O
    DONKER, AJM
    NETHERLANDS JOURNAL OF MEDICINE, 1990, 36 (5-6): : 267 - 278
  • [44] PROBUCOL AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL
    GAGNE, C
    LUPIEN, PJ
    BRUN, D
    MOORJANI, S
    TOUSSAINT, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1980, 123 (05) : 356 - 356
  • [45] HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND ATHEROSCLEROSIS
    NG, DS
    HEGELE, RA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1993, 149 (12) : 1807 - 1808
  • [46] EFFECT OF SPECIFIC BINDING OF HIGH-DENSITY-LIPOPROTEIN TO EEL HEPATOCYTES ON THEIR SECRETION OF LIPOPROTEIN
    JIBRIL, N
    MORI, Y
    TANAKA, Y
    SAKATA, T
    MIKI, H
    SAKAKIBARA, T
    SATO, M
    HAYASHI, S
    CELL STRUCTURE AND FUNCTION, 1995, 20 (05) : 301 - 310
  • [47] ISRADIPINE IN CHRONIC-RENAL-FAILURE - ANTIHYPERTENSIVE EFFECT AND RENAL PROTECTION
    CAVATORTA, A
    COGHI, P
    BORGHETTI, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (12): : 1538 - 1550
  • [48] HETEROGENEITY OF HIGH-DENSITY-LIPOPROTEIN PARTICLES
    FRUCHART, JC
    AILHAUD, G
    BARD, JM
    CIRCULATION, 1993, 87 (04) : 22 - 27
  • [49] HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND LONGEVITY
    NIKKILA, M
    HEIKKINEN, J
    AGE AND AGEING, 1990, 19 (02) : 119 - 124
  • [50] HIGH-DENSITY-LIPOPROTEIN PARTICLES IN OCTOGENARIANS
    LUC, G
    BARD, JM
    LUSSIERCACAN, S
    BOUTHILLIER, D
    PARRA, HJ
    FRUCHART, JC
    DAVIGNON, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (12): : 1238 - 1243